Rothschild & Co Asset Management US’s AMAG Pharmaceuticals, Inc. AMAG Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2017
Q3 | – | Sell |
-40,132
| Closed | -$738K | – | 568 |
|
2017
Q2 | $738K | Sell |
40,132
-1,812
| -4% | -$33.3K | 0.01% | 400 |
|
2017
Q1 | $946K | Sell |
41,944
-3,102
| -7% | -$70K | 0.01% | 373 |
|
2016
Q4 | $1.57M | Buy |
45,046
+35,360
| +365% | +$1.23M | 0.02% | 354 |
|
2016
Q3 | $237K | Buy |
9,686
+244
| +3% | +$5.97K | ﹤0.01% | 523 |
|
2016
Q2 | $226K | Sell |
9,442
-299,723
| -97% | -$7.17M | ﹤0.01% | 551 |
|
2016
Q1 | $7.23M | Buy |
309,165
+5,073
| +2% | +$119K | 0.14% | 222 |
|
2015
Q4 | $9.18M | Buy |
304,092
+15,539
| +5% | +$469K | 0.17% | 196 |
|
2015
Q3 | $11.5M | Buy |
288,553
+162,668
| +129% | +$6.46M | 0.22% | 156 |
|
2015
Q2 | $8.69M | Buy |
125,885
+1,240
| +1% | +$85.6K | 0.16% | 211 |
|
2015
Q1 | $6.81M | Buy |
124,645
+31,657
| +34% | +$1.73M | 0.13% | 235 |
|
2014
Q4 | $3.96M | Buy |
92,988
+173
| +0.2% | +$7.37K | 0.08% | 276 |
|
2014
Q3 | $2.96M | Sell |
92,815
-3,680
| -4% | -$117K | 0.06% | 300 |
|
2014
Q2 | $2M | Hold |
96,495
| – | – | 0.04% | 326 |
|
2014
Q1 | $1.87M | Sell |
96,495
-44,812
| -32% | -$867K | 0.04% | 337 |
|
2013
Q4 | $3.43M | Buy |
141,307
+27,258
| +24% | +$662K | 0.08% | 310 |
|
2013
Q3 | $2.45M | Sell |
114,049
-20,006
| -15% | -$430K | 0.05% | 323 |
|
2013
Q2 | $2.98M | Buy |
+134,055
| New | +$2.98M | 0.07% | 315 |
|